BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 20519548)

  • 1. TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97.
    Ritson GP; Custer SK; Freibaum BD; Guinto JB; Geffel D; Moore J; Tang W; Winton MJ; Neumann M; Trojanowski JQ; Lee VM; Forman MS; Taylor JP
    J Neurosci; 2010 Jun; 30(22):7729-39. PubMed ID: 20519548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.
    Custer SK; Neumann M; Lu H; Wright AC; Taylor JP
    Hum Mol Genet; 2010 May; 19(9):1741-55. PubMed ID: 20147319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model.
    Chang YC; Hung WT; Chang YC; Chang HC; Wu CL; Chiang AS; Jackson GR; Sang TK
    PLoS Genet; 2011 Feb; 7(2):e1001288. PubMed ID: 21304887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis.
    Nalbandian A; Donkervoort S; Dec E; Badadani M; Katheria V; Rana P; Nguyen C; Mukherjee J; Caiozzo V; Martin B; Watts GD; Vesa J; Smith C; Kimonis VE
    J Mol Neurosci; 2011 Nov; 45(3):522-31. PubMed ID: 21892620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic variability in three families with valosin-containing protein mutation.
    Spina S; Van Laar AD; Murrell JR; Hamilton RL; Kofler JK; Epperson F; Farlow MR; Lopez OL; Quinlan J; DeKosky ST; Ghetti B
    Eur J Neurol; 2013 Feb; 20(2):251-8. PubMed ID: 22900631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy.
    Ju JS; Weihl CC
    Hum Mol Genet; 2010 Apr; 19(R1):R38-45. PubMed ID: 20410287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice.
    Rodriguez-Ortiz CJ; Hoshino H; Cheng D; Liu-Yescevitz L; Blurton-Jones M; Wolozin B; LaFerla FM; Kitazawa M
    Am J Pathol; 2013 Aug; 183(2):504-15. PubMed ID: 23747512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease.
    Ju JS; Fuentealba RA; Miller SE; Jackson E; Piwnica-Worms D; Baloh RH; Weihl CC
    J Cell Biol; 2009 Dec; 187(6):875-88. PubMed ID: 20008565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced ATPase activities as a primary defect of mutant valosin-containing proteins that cause inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia.
    Manno A; Noguchi M; Fukushi J; Motohashi Y; Kakizuka A
    Genes Cells; 2010 Aug; 15(8):911-22. PubMed ID: 20604808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
    Weihl CC; Dalal S; Pestronk A; Hanson PI
    Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy.
    Guinto JB; Ritson GP; Taylor JP; Forman MS
    Acta Neuropathol; 2007 Jul; 114(1):55-61. PubMed ID: 17457594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.
    Weihl CC; Pestronk A; Kimonis VE
    Neuromuscul Disord; 2009 May; 19(5):308-15. PubMed ID: 19380227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleocytoplasmic shuttling of valosin-containing protein (VCP/p97) regulated by its N domain and C-terminal region.
    Song C; Wang Q; Song C; Lockett SJ; Colburn NH; Li CC; Wang JM; Rogers TJ
    Biochim Biophys Acta; 2015 Jan; 1853(1):222-32. PubMed ID: 25447673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death.
    Gitcho MA; Strider J; Carter D; Taylor-Reinwald L; Forman MS; Goate AM; Cairns NJ
    J Biol Chem; 2009 May; 284(18):12384-98. PubMed ID: 19237541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations.
    Neumann M; Mackenzie IR; Cairns NJ; Boyer PJ; Markesbery WR; Smith CD; Taylor JP; Kretzschmar HA; Kimonis VE; Forman MS
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):152-7. PubMed ID: 17279000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of a drosophila IBMPFD model reveals potential pathogenic mechanisms.
    Chan HT; Lee TR; Huang SH; Lee HY; Sang TK; Chan HL; Lyu PC
    Mol Biosyst; 2012 Jun; 8(6):1730-41. PubMed ID: 22481368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The heterozygous R155C VCP mutation: Toxic in humans! Harmless in mice?
    Clemen CS; Winter L; Strucksberg KH; Berwanger C; Türk M; Kornblum C; Florin A; Aguilar-Pimentel JA; Amarie OV; Becker L; Garrett L; Hans W; Moreth K; Neff F; Pingen L; Rathkolb B; Rácz I; Rozman J; Treise I; Fuchs H; Gailus-Durner V; de Angelis MH; Vorgerd M; Eichinger L; Schröder R
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2770-2777. PubMed ID: 30100055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different dynamic movements of wild-type and pathogenic VCPs and their cofactors to damaged mitochondria in a Parkin-mediated mitochondrial quality control system.
    Kimura Y; Fukushi J; Hori S; Matsuda N; Okatsu K; Kakiyama Y; Kawawaki J; Kakizuka A; Tanaka K
    Genes Cells; 2013 Dec; 18(12):1131-43. PubMed ID: 24215292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valosin-containing protein (VCP/p97) inhibitors relieve Mitofusin-dependent mitochondrial defects due to VCP disease mutants.
    Zhang T; Mishra P; Hay BA; Chan D; Guo M
    Elife; 2017 Mar; 6():. PubMed ID: 28322724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel VCP mutation as the cause of atypical IBMPFD in a Chinese family.
    Gu JM; Ke YH; Yue H; Liu YJ; Zhang Z; Zhang H; Hu WW; Wang C; He JW; Hu YQ; Li M; Fu WZ; Zhang ZL
    Bone; 2013 Jan; 52(1):9-16. PubMed ID: 23000505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.